1. Oral Solid Tablet
  2. Recombinant Protein

Zelgen has successfully built two commercial GMP manufacturing facilities for oral solid tablet preparations (11,000 square meters) and recombinant biologics (4,000 square meters), as well as ancillary facilities of power supply and sewage treatment systems. Zelgen has obtained Drug Manufacturing License from the NMPA. These facilities in compliance with cGMP guidelines provide us with significant manufacturing capacity, cost effectiveness and competitive advantage.